Nikhil Jain – Galaxy International
View Detailed Executive Profile →Professional Overview
- Nikhil Jain founded Galaxy International in June 2021, leading the organization in its operations and strategic direction.
- Prior to establishing Galaxy International, Nikhil served as the Head of API Product Management, Portfolio and Business Development at Dr. Reddy's Laboratories from January to May 2021, focusing on product strategies and partnerships.
- From March 2019 to January 2020, Nikhil held the position of Head of API Sales and Business Development at Jubilant Pharmaceuticals, contributing significantly to sales growth and business expansion.
- Nikhil has extensive experience with Galaxy International, having worked as a Consultant from August 2018 to February 2019, where insights into market needs were provided to enhance the organization’s offerings.
- Between August 2016 and July 2018, Nikhil led the API Sales and Portfolio divisions for Cipla, catering to both the European and Indian markets, showcasing a strong inclination towards international business development.
- From April 2015 to July 2016, Nikhil was the Head of Supply Chain and Portfolio API at Cipla, streamlining operations to optimize product availability and market penetration.
- Nikhil transitioned through various leadership roles at Dr. Reddy's Laboratories from 2007 to 2011, including Director positions focused on sales, marketing, and product management, leading to enhanced operational efficiencies.
- Throughout the career, Nikhil has demonstrated expertise in portfolio management, business development, and strategic sales across multiple organizations, highlighting a robust background in the pharmaceutical sector.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Cipla | Head - API Portfolio, Strategy & BD | Oct 2013 – Mar 2015 |
| Dr. Reddy's Laboratories | Sr Director - Portfolio Management, Business Development and Product Management | Oct 2011 – Sep 2013 |
| Dr. Reddy's Laboratories | Director - Sales, Marketing and Business Development | May 2007 – Jan 2011 |
| Jubilant Pharmaceuticals | Head API Sales and BD | Mar 2019 – Jan 2020 |
| Dr. Reddy's Laboratories | Senior Manager - North America Sales and Marketing | Mar 2006 – Apr 2007 |
| Dr. Reddy's Laboratories | Manager - Business Development - Oncology and Biologics | Mar 2003 – Mar 2004 |
| Dr. Reddy's Laboratories | Head of API Product Management, Portfolio and BD | Jan 2020 – May 2021 |
| Dr. Reddy's Laboratories | Director - Sales, Marketing and Business Development | Feb 2011 – Sep 2011 |
| Galaxy International | Consultant | Aug 2018 – Feb 2019 |
| Cipla | Head- API Sales (EU & India) & API Portfolio | Aug 2016 – Jul 2018 |
| Cipla | Head - Supply Chain and Portfolio API | Apr 2015 – Jul 2016 |
| Dr. Reddy's Laboratories | Senior Manager - PPIC, API | Apr 2004 – Feb 2006 |
| Galaxy International | Founder | Jun 2021 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Galaxy International corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Nikhil Jain's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Galaxy International's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)